[go: up one dir, main page]

ES362231A1 - Dimethylbiguanide Derivative - Google Patents

Dimethylbiguanide Derivative

Info

Publication number
ES362231A1
ES362231A1 ES362231A ES362231A ES362231A1 ES 362231 A1 ES362231 A1 ES 362231A1 ES 362231 A ES362231 A ES 362231A ES 362231 A ES362231 A ES 362231A ES 362231 A1 ES362231 A1 ES 362231A1
Authority
ES
Spain
Prior art keywords
dimethylbiguanide
derivative
dragees
gelatine
capsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES362231A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CERPHA
Original Assignee
CERPHA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CERPHA filed Critical CERPHA
Publication of ES362231A1 publication Critical patent/ES362231A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention comprises the title compound, and a process for making it by mixing the components (or their salts) in a common solvent. Therapeutic compositions for oral administration comprise the above compound, which is hypoglycaemically active, e.g. in the form of capsules, gelatine-coated pills, tablets or dragees.
ES362231A 1968-01-08 1969-01-08 Dimethylbiguanide Derivative Expired ES362231A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR135175A FR7116M (en) 1968-01-08 1968-01-08

Publications (1)

Publication Number Publication Date
ES362231A1 true ES362231A1 (en) 1970-12-01

Family

ID=8644240

Family Applications (1)

Application Number Title Priority Date Filing Date
ES362231A Expired ES362231A1 (en) 1968-01-08 1969-01-08 Dimethylbiguanide Derivative

Country Status (6)

Country Link
BR (1) BR6905385D0 (en)
CH (1) CH501600A (en)
DE (1) DE1900772C3 (en)
ES (1) ES362231A1 (en)
FR (1) FR7116M (en)
GB (1) GB1187946A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080472A (en) * 1974-03-22 1978-03-21 Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. Metformin 2-(p-chlorophenoxy)-2-methylpropionate
FR2264525B1 (en) * 1974-03-22 1977-11-04 Expl Marques Brevets Et
FR2275199A1 (en) * 1974-06-19 1976-01-16 Cerpha Dimethylbiguanide (4-chlorophenoxy)-isobutyrate - for use as a hypolipaemic agent
FR2585572B3 (en) * 1985-07-31 1987-12-31 Hugelin Andre NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON SALT OF P. CHLOROPHENOXYACETIC ACID FOR THE TREATMENT OF NEUROPATHIES AND PROVIDING NERVOUS REGENERATION
FR2796551B1 (en) * 1999-07-23 2003-07-25 Lipha NOVEL METFORMIN SALTS, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2796940B1 (en) * 1999-07-26 2005-04-08 Lipha NOVEL METFORMIN SALTS, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

Also Published As

Publication number Publication date
GB1187946A (en) 1970-04-15
DE1900772B2 (en) 1979-06-07
FR7116M (en) 1969-07-15
BR6905385D0 (en) 1973-02-08
CH501600A (en) 1971-01-15
DE1900772C3 (en) 1980-01-31
DE1900772A1 (en) 1969-10-09

Similar Documents

Publication Publication Date Title
DK112191B (en) Process for the preparation of pharmaceutical compositions for oral administration, such as granules, tablets, gelatin capsules or dragees.
IL50836A (en) Dihydrocyclosphorin c,a process for the preparation thereoof and pharmaceutical compositions containing this compound
GB1204580A (en) Pharmaceutical dosage forms
CA967484A (en) Pharmaceutical compositions containing a vitamin a derivative
ES445467A1 (en) Tablets
PH9997A (en) Pharmacologically active n(1h-tetrazol-5-yl)quinaldamide compounds and compositions containing them
ES362231A1 (en) Dimethylbiguanide Derivative
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL43749A0 (en) Novel cyclopropylmethylamine derivatives,their production and pharmaceutical compositions containing them
IL36506A0 (en) New heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL36571A0 (en) Derivatives of dibenzo(a-d)cycloheptadiene and-triene,their preparation and pharmaceutical compositions containing them
GB1126153A (en) Novel polygalacturonic acid derivative
IL34938A0 (en) Pharmaceutical compositions containing a 2,4-thiazolidine-dione-2 thiosemicarbazone derivatives
ES294897A1 (en) Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding)
IL36286A0 (en) Erythromycylamine compounds,process for the preparation thereof and pharmaceutical compositions containing the same
GB1043842A (en) Pharmaceutical compositions for treating headache
IL36285A0 (en) Erythromycylamine compounds,processes for preparation thereof and pharmaceutical compositions containing them
CA937866A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
IL36777A0 (en) A new 2,3-diazabicyclo(5,4,3)-undecapentaene derivative,its preparation and pharmaceutical compositions containing it
IL50399A (en) Substituted sulphoximides,a process for their preparation and pharmaceutical compositions containing these compounds
IL37116A0 (en) Pharmaceutical compositions containing derivatives of l-(3,4-dihydroxy-phenyl)alanine
IL37629A0 (en) Pharmaceutical compositions comprising a derivative of hydantoin
GB914512A (en) Novel therapeutic compositions
IL43684A0 (en) A new derivative of l-4-hydroxy-proline and salts thereof,a process for their preparation and pharmaceutical compositions containing them
GB998051A (en) Pharmaceutical compositions comprising n-(5-nitro-2-furfurylidene)-1-aminohydentoin, tetracycline and 2-amino-d-glucose